Post Deleted
…………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. ……………………..
…………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. ……………………..
| +44 | Who is your favorite philosopher? | 28 | 2d |
| +27 | Without a tribe | 8 | 2d |
| +20 | Why is AI wrong? | 6 | 1d |
| +15 | How the Hell Do People Actually Get Into Private Golf Clubs? | 8 | 1h |
| +13 | Definitive Updated Wharton Club Rank 2026 | 4 | 2d |
| +10 | POLL: Optimistic or Pessimistic? | 5 | 49m |
| +6 | Giving AI Impossible Tasks | 8 | 1h |
| +3 | Unhinged euphemisms | 3 | 1d |
| 0 | Why do Asians fake their names? | 20 | 1h |
Career Resources
Not to hijack post, but has anyone watched and recommend Shkreli's yt analysis of biotech/pharma companies?
Gotta be honest DCFs in healthcare are used very infrequently. Why would you use a perpetuity formula when the cash flows will significantly change once the patent expires and the market floods with generics?
What method is typically used to value companies in healthcare?
Why are you looking for FV and not PV?
Ipsa numquam temporibus possimus ipsam dolorum. Accusamus perspiciatis quod minus ut sapiente et totam. Alias voluptate ipsum facere dolorum voluptatem porro deserunt. Aspernatur odit beatae rerum eligendi. Est est numquam quisquam molestiae voluptatibus. Ab molestiae sunt recusandae facilis. Ex est delectus officia voluptatem.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...